Issue of warrants
February 18 2011 - 7:41AM
UK Regulatory
TIDMRGT
18 February 2011
ReGen Therapeutics Plc
(the "Company")
to be renamed Alexander David Investments PLC
Issue of warrants
Further to the placing of 300,000,000 new ordinary shares of 0.01 pence in the
Company ("Ordinary Shares") at 0.5 pence per share (the "Placing Shares")
announced earlier today, the Company has issued one new warrant for every ten
Placing Shares held. This equates to the issue of warrants over 30,000,000
shares. Each warrant entitles the holder to subscribe for one new Ordinary Share
in the Company at an exercise price of 0.5 pence per share. The warrants are
exercisable until 18 February 2013.
The total number of warrants now in issue is 155,388,604, comprising:
+---------------------------+------------------+--------------+----------------+
|Warrantholder |Number of warrants|Exercise price|Expiry date |
| | | | |
+---------------------------+------------------+--------------+----------------+
|Pre-placing shareholders1 | 8,944,086| 0.5p|18 February 2013|
| | | | |
+---------------------------+------------------+--------------+----------------+
|Placing shareholders2 | 30,000,000| 0.5p|18 February 2013|
| | | | |
+---------------------------+------------------+--------------+----------------+
|Alexander David Securities| 116,444,518| 0.5p|18 February 2016|
|Limited | | | |
| | | | |
+---------------------------+------------------+--------------+----------------+
1 Shareholders in the Company as at 14 February 2011
2 Participants in the placing announced on 18 February 2011
Enquiries:
ReGen Therapeutics Plc +44 20 7153 4920
Percy Lomax
Cairn Financial Advisers LLP +44 20 7148 7900
Nominated Adviser
Liam Murray / Avi Robinson
Alexander David Securities Limited +44 20 7448 9820
Broker
David Scott / Nick Bealer
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: ReGen Therapeutics Plc via Thomson Reuters ONE
[HUG#1490556]
Argent Biopharma (LSE:RGT)
Historical Stock Chart
From Sep 2024 to Oct 2024
Argent Biopharma (LSE:RGT)
Historical Stock Chart
From Oct 2023 to Oct 2024